K. BİR YÜCEL Et Al. , "Niraparib-induced pure red cell aplasia," Journal of Oncology Pharmacy Practice , vol.30, no.1, pp.210-214, 2024
BİR YÜCEL, K. Et Al. 2024. Niraparib-induced pure red cell aplasia. Journal of Oncology Pharmacy Practice , vol.30, no.1 , 210-214.
BİR YÜCEL, K., YILDIZ, Ş., SÜTCÜOĞLU, O., Güvercin, F. S., UYAR GÖÇÜN, F. P., ÖZDEMİR, N., ... YAZICI, O.(2024). Niraparib-induced pure red cell aplasia. Journal of Oncology Pharmacy Practice , vol.30, no.1, 210-214.
BİR YÜCEL, KADRİYE Et Al. "Niraparib-induced pure red cell aplasia," Journal of Oncology Pharmacy Practice , vol.30, no.1, 210-214, 2024
BİR YÜCEL, KADRİYE B. Et Al. "Niraparib-induced pure red cell aplasia." Journal of Oncology Pharmacy Practice , vol.30, no.1, pp.210-214, 2024
BİR YÜCEL, K. Et Al. (2024) . "Niraparib-induced pure red cell aplasia." Journal of Oncology Pharmacy Practice , vol.30, no.1, pp.210-214.
@article{article, author={KADRİYE BİR YÜCEL Et Al. }, title={Niraparib-induced pure red cell aplasia}, journal={Journal of Oncology Pharmacy Practice}, year=2024, pages={210-214} }